Procura Crosses the 170 Million Mobile Electronic Visit Verification Mark

The Procura mobile products passed a 170 million-visit milestone this week, reporting an uptick in mobile EVV usage in recent years as solutions that were pioneered by Procura years ago have been proven at the enterprise level.
Complia Logo.jpg

Victoria, British Columbia (August 27, 2019) - Complia Health announced today that its Procura health management platform has crossed the 170 million mobile Electronic Visit Verification (EVV) mark. EVV is the use of mobile technologies that permit home and community care workers to check in and out of a client service visit. This feature set serves to replace paper timesheets that are time consuming to verify, and provides an added mobile worker safety capability.

"The Procura platform released its first mobile product in 2002," said Scott Overhill, Complia's CSO and Procura Global Division GM, "however, we've only been keeping track of mobile EVV statistics since 2012 and therefore the actual number is likely much higher. The 170+ million mark represents over 22% of all client visits that have been scheduled in Procura. This is up 12% from 2014. The increase is significant in large part due to the correlations we've seen: customers who adopt our mobile products realize gains in efficiency, as well as the benefit of a more connected workforce."

The Procura mobile products feature discipline-specific observations, assessments and clinical documentation capabilities in the form of a mobile community EHR system that operates seamlessly with the Procura Scheduling and EVV modules. "The Procura mobile products offer far greater capabilities than other 'stand-alone' mobile EVV solutions," stated Martin Ambrose, CEO of Complia Health. He continued, "We are on a mission to eliminate paper in home and community care. We're pleased with the progress of mobile adoption and we see it accelerating as our enterprise customers further embrace the solutions."

The development and success of the Procura platform and its mobile products are consistent with the Complia Health mission: to enhance the healthcare experience. Complia Health is continuing to demonstrate its experience and leadership in delivering innovative, differentiated mobile technologies within its software portfolios in the US, Canada, Australia and New Zealand.

About Complia Health
Complia Health is a leading global provider of technology and expertise for the post-acute and long-term care markets. Nearly 3,000 home health, hospice, palliative care, residential care and community care organizations count on Complia Health for the clinical, operational, and financial solutions required to profitability deliver quality care to its clients. Complia Health's innovative products—including Procura, ContinuLink, Suncoast, Igea, and Progresa—are supported by a team of global health and technology experts located in the United States, Canada, and Australia. For more information, visit

About Carrick Capital Partners
Who We Are
A firm of enterprise software, SaaS, and technology enabled services investors and operating executives with substantial experience founding, scaling, and optimizing market leading businesses.
Our Approach
We work with management to identify and improve critical areas of their business - focusing on the priorities that align with our experiences and that will deliver the highest strategic impact in both the short-term and long-run.
Why We Are Different
We have a concentrated number of companies in our portfolio so that we can build substantial relationships with each management team and ensure our firm's commitment to each company's goals.
Latest News
Saviynt Logo.jpg
Identity Solution Provider Realized 64% Year-Over-Year Growth in New Business and Expanded Both its Customer Base & Employees by 48%
September 20, 2021
Mavenlink Logo.jpg
Breadth of Leadership Position Addresses Full Range of Professional Services Technology Needs
September 9, 2021
Edtech Industry Executive's Experience Will Lead Flatiron Into Next Phase of Growth
September 7, 2021